Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 2.1 Share Exchange and Reorganization Agreement
- 3.1 Amended and Restated Articles of Incorporation
- 10.1 Form of Subscription Agreement
- 10.2 Registration Rights Agreement
- 10.3 Form of Investor Warrant
- 16 Letter from M&K Cpas, PLLC
- 99.1 Unaudited Pro Forma Condensed Financial Statements
CTXR similar filings
- 14 Oct 15 Citius Pharmaceuticals, Inc. Announces Appointment of Mr. Suren Dutia to Its Board of Directors
- 6 Oct 15 Citius Pharmaceuticals Announces Myron Holubiak, Former President of Roche Laboratories, Inc., USA, has Joined Its Board of Directors
- 1 May 15 Unregistered Sales of Equity Securities
- 18 Sep 14 Unaudited Pro Forma Condensed Financial Statements
- 10 Jun 13 Changes in Control of Registrant
Filing view
External links
EXHIBIT 16
September 19, 2014
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Ladies and Gentlemen:
We have read the statements included under Item 4.01 of Form 8-K dated September 12, 2014 of Citius Pharmaceuticals, Inc. (formerly Trail One, Inc.) to be filed with the Securities and Exchange Commission and we agree with such statements insofar as they relate to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ M&K CPAS, PLLC
M&K CPAS, PLLC
Houston, Texas